CHARLES IRVINE REAL ESTATE LIMITED
REGISTERED NUMBER: 10147434
STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2023
|
|
|
|
|
Called up share capital not paid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepayments and accrued income
|
|
|
|
|
Creditors: amounts falling due within one year
|
|
|
|
|
Net current (liabilities)/assets
|
|
|
|
|
Total assets less current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
Charles Irvine Real Estate Limited is a private company limited by shares, incorporated in England and Wales, United Kingdom. The address of the registered office is given on the Company Information page of these financial statements.
Average number of employees
|
The average monthly number of employees, including directors, during the year was 3 (2022 - 3).
Related party transactions
|
At the year end, the company was owed £- (2022: £618 ) from D I Babington Smith.
At the year end, the company was owed a balance of £5,000 (2022: £Nil) from its parent Charles Irvine Group LLP.
At the year end, the company owes a balance of £9,000 (2022: £12,000) to its sister company Charles Irvine Capital Limited.
|
CHARLES IRVINE REAL ESTATE LIMITED
REGISTERED NUMBER: 10147434
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 SEPTEMBER 2023
Directors' confirmations
The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
|